Ticker
GALTCompany Name
GALECTIN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -35.62M | -14.79% | $ 240.87M |
3/31/2025 | $ -37.35M | -44.71% | $ 83.54M |
12/31/2024 | $ -41.77M | -54.19% | $ 77.08M |
9/30/2024 | $ -33.68M | -19.51% | $ 172.6M |
6/30/2024 | $ -32.78M | -23.39% | $ 140.13M |
3/31/2024 | $ -34.28M | -18.02% | $ 190.17M |
12/31/2023 | $ -32.97M | -22.28% | $ 147.95M |
9/30/2023 | $ -35.5M | -29.44% | $ 120.6M |
6/30/2023 | $ -36.21M | -40.79% | $ 88.78M |
3/31/2023 | $ -33.81M | -34.6% | $ 97.71M |
FCF / Market Cap
(=) FCF Yield
FCF Yield for GALECTIN THERAPEUTICS INC is calculated as follows: FCF [ $ -18.95M ] / Market Cap [ $ 143.83M ]
(=) FCF Yield [ -13.17% ]
Minimum
Dec 31, 2024
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.59% |
median | 3.22% |
std | 11.38% |